By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AbbVie 



      U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.


Key Statistics


Email:
Ownership: Public

Web Site: AbbVie
Employees:
Symbol: ABBV
 



Industry
Pharmaceutical






Company News
AbbVie (ABBV) And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy 3/19/2015 7:05:27 AM
AbbVie (ABBV) Will Add 100 Jobs in $30 Million Puerto Rico Expansion 3/18/2015 11:54:13 AM
AbbVie (ABBV)'s Dermatology Leadership Showcased With HUMIRA (adalimumab) Data At American Academy of Dermatology 2015 Annual Meeting 3/17/2015 10:59:34 AM
Ablynx (ABLYF) Initiates The First Of Two Phase IIb Ra Studies With Its Anti-Il-6R Nanobody, Partnered With AbbVie (ABBV) 3/17/2015 7:19:27 AM
AbbVie (ABBV) Elated as Pharmacyclics (PCYC)'s Imbruvica Shines in Combo Trial 3/17/2015 5:56:00 AM
AbbVie (ABBV), Johnson & Johnson (JNJ) Tempted to Take Over $650 Million Galapagos (GLPG.BR) 3/10/2015 6:02:37 AM
AbbVie (ABBV) To Present At Barclays Global Health Care Conference 3/6/2015 7:29:12 AM
AbbVie (ABBV) CEO Believes New Form of Humira Could Confront Generics 3/6/2015 6:46:38 AM
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/5/2015 12:45:43 PM
Testosterone Drugs Like AbbVie (ABBV)'s Overused: FDA 3/5/2015 6:30:37 AM
12345678910...
//-->